Cargando…
Prediction of chemotherapeutic resistance in serous ovarian cancer with low-density custom microarray
Autores principales: | Zhu, Hong-Lan, Zeng, Hao-Xia, Liang, Xu-Dong, Chang, Xiao-Hong, Wang, Jian-Liu, Cui, Heng, Wei, Li-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147646/ https://www.ncbi.nlm.nih.gov/pubmed/32106126 http://dx.doi.org/10.1097/CM9.0000000000000717 |
Ejemplares similares
-
Trends of low-grade serous ovarian carcinoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018) -
Treatment of liver metastases in patients with epithelial ovarian cancer
por: Deng, Hao, et al.
Publicado: (2021) -
Serous ovarian carcinoma in patients with Lynch syndrome: Caution is warranted
por: Benusiglio, Patrick R., et al.
Publicado: (2018) -
Custom Design and Analysis of High-Density Oligonucleotide Bacterial Tiling Microarrays
por: Thomassen, Gard O. S., et al.
Publicado: (2009) -
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers
por: Di Lorenzo, Paolo, et al.
Publicado: (2022)